FEATURES:

o behind the scenes of highly cited research in these interviews and first-person essays featuring authors of the highly cited papers in Schizophrenia, as well as the top-cited scientists in this area. More interviews and essays are available in the other Special Topics areas, as well as in incites and Science Watch which are the other editorial components of ISI Essential Science Indicators from ISI. In addition, the citation statistics for these and other researchers are available through ISI Essential Science Indicators data.
An interview with: Dr. William Carpenter December 2001		William Carpenter discusses his work in schizophrenia research in this interview. He has authored 53 papers, which have been cited a total of 1,207 times, placing him among the top 20 most-cited schizophrenia researchers of the past decade. Dr. Carpenter has 40 papers in Psychiatry/Psychology cited 1,539 times in the current version of the ISI Essential Science Indicators Web product.   [read]
An essay by: Dr. Carol A. Tamminga December 2001		In this essay, Dr. Carol A. Tamminga talks about how she became interested in science and her motivations and experiences in doing schizophrenia research. Dr. Tamminga is the lead author of the paper, "Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome," (Archives of General Psychiatry 49[7]: 522-30, July 1992). In a Special Topics analysis of schizophrenia research over the past decade, this paper placed among the top 25 papers, with a total of 198 citations.   [read]
An essay by: Dr. Richard Wyatt December 2001		Richard Wyatt of the National Institute of Mental Health (NIMH) is the author of "Neuroleptics and the natural course of schizophrenia," (Schizophrenia Bulletin 17[2]: 325-51, 1991), a paper which, in our survey of high-impact papers in schizophrenia research, ranked among the top 25 papers published in this field in the past decade. In this essay, Dr. Wyatt relates how he started his career as a schizophrenia researcher as well as the impact his highly cited paper has had on the academic and medical communities. [read]
An essay by: Dr. Daniel C. Javitt November 2001		Dr. Daniel C. Javitt talks about his highly cited paper, "Recent advances in the phencyclidine model of schizophrenia," (American Journal of Psychiatry, 148[10]: 1301-8, October 1991). In our analysis of high-impact papers in the field of schizophrenia, this paper was cited 403 times, placing it among the five most-cited papers in this area in the past decade.  [read]
An interview with: Dr. Peter McGuffin  November 2001		In this interview, Dr. Peter McGuffin, Director of the Social, Genetic, and Developmental Psychiatric Research Centre at King’s College, London, talks about his research on the genetic basis of schizophrenia and other psychiatric disorders. He has contributed to 99 papers on schizophrenia, which have been cited a total of 1,312 times. These citations make Dr. McGuffin one of the top 15 most-cited authors in schizophrenia research of the past decade.  [read]
An essay by: Dr. Philip Seeman  November 2001		In this essay, Dr. Philip Seeman of the University of Toronto discusses his work in psychosis and brain dopamine receptors. He is among the top 30 most-cited schizophrenia researchers of the 1990’s, with 22 papers cited a total of 924 times. ISI Essential Science Indicators Web product indicates that Dr. Seeman has a variety of papers published in the fields of Neuroscience & Behavior and Psychiatry/Psychology, as well as in the Multidisciplinary field.  [read]
An essay with: Dr. Jacqueline Crawley October 2001		The review article, "Biological actions of cholecystokinin," (Peptides, 15[4]: 731-755, 1994) has become one of the top 30 most-cited papers in schizophrenia research of the past decade, with 179 citations to date. In this essay, Dr. Jacqueline Crawley describes the role of cholecystokinin in her research and the factors leading up to the 1994 Peptides paper. Dr. Crawley is the Chief of the Section of Behavioral Neuropharmacology at the National Institute of Mental Health. [read]
An interview with: Dr. Kenneth Davis September 2001		Dr. Kenneth Davis of the Mount Sinai School of Medicine in New York City discussed his highly cited work in schizophrenia research, and how that research has led him to study Alzheimer’s disease. Sixty-eight of Dr. Davis’s published papers were included in our analysis of high-impact schizophrenia research. These 68 papers have been cited a total of 967 times. His most-cited paper is "Dopamine in schizophrenia—a review and reconceptualization," (American Journal of Psychiatry, 148 [11]: 1474-86, November 1991). This paper has been cited over 386 times, making it the third most-cited paper in schizophrenia research of the 1990s. [read]
An interview with: Dr. David Kavanagh September 2001		David Kavanagh of the University of Queensland in Australia is the author of the review, "Recent developments in expressed emotion in schizophrenia," (British Journal of Psychiatry, 160: 601-20, May 1992). This paper has been cited 162 times to date, placing it among the top 40 most-cited papers in schizophrenia research of the 1990s. In this Special Topics interview, Dr. Kavanagh discusses his highly cited paper as well as his current research in the comorbidity of substance abuse and mental illness. [read]
An interview with: Dr. Stephen R. Marder August 2001		Dr. Stephen R. Marder discussed his highly cited work and his involvement in schizophrenia research. Dr. Marder is the author of the most-cited schizophrenia research paper of the 1990s, "Risperidone in the treatment of schizophrenia," (American Journal of Psychiatry, 151[6]: 825-35, June 1994), which has been cited 444 times to date. Dr. Marder has also contributed to 43 schizophrenia research papers, which have been cited a total of 851 times to date. . [read]
An interview with: Dr. Daniel R. Weinberger August 2001		Daniel R. Weinberger, chief of the clinical brain disorders branch at the National Institute of Mental Health, talks about his highly cited work on schizophrenia. In our analysis, 158 of Dr. Weinberger’s papers were cited a total of 2,413 times, making him the second-most-cited scientist of the 1990s in schizophrenia research. [read]
An essay by: Dr. Anthony Grace July 2001		Dr. Anthony Grace, Professor of Neuroscience and Psychiatry at the University of Pittsburgh, is the author of "Phasic versus tonic dopamine release and the modulation of dopamine system responsivity – a hypothesis for the etiology of schizophrenia," (Neuroscience, 41[1]: 1-24, 1991). This paper has been cited 349 times to date, placing it among the top 10 most-cited schizophrenia research papers of the past decade. In this essay, Dr. Grace discusses how he came to write this paper and the impact it has had on other disciplines. [read]
An interview with: Dr. Martha Shenton July 2001		Dr. Martha E. Shenton of Harvard Medical School talks about the influences and experiences that have shaped her career in neuroscience. Dr. Shenton is the Director of the Clinical Neuroscience Division and an Associate Professor in the Department of Psychiatry at Harvard Medical School. In addition, she is a Director of Neuroimaging Studies in Psychiatry and Behavioral Science and a Research Associate in the Department of Radiology at Brigham & Women’s Hospital.  [read]